Solen Therapeutics Files Q1 2025 10-Q
Ticker: SLNO · Form: 10-Q · Filed: May 7, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
Related Tickers: SLNO
TL;DR
Solen Therapeutics (SLNO) filed its Q1 2025 10-Q. Check financials.
AI Summary
Solen Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Capnia, Inc., is involved in electromedical and electrotherapeutic apparatus. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational status of Solen Therapeutics, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-Q, there are inherent risks associated with financial performance and market conditions.
Key Players & Entities
- SOLENO THERAPEUTICS INC (company) — Filer
- Capnia, Inc. (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250507 (date) — Filing date
- REDWOOD CITY, CA (location) — Business address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the first quarter of 2025.
When was this 10-Q filed with the SEC?
The filing date is 20250507.
What was Solen Therapeutics Inc. formerly known as?
The company was formerly known as Capnia, Inc., with a date of name change on 20100219.
What is the Standard Industrial Classification (SIC) code for Solen Therapeutics Inc.?
The SIC code is 3845, categorized under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
What is the business address of Solen Therapeutics Inc.?
The business address is 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).